Triple negative breast cancer (TNBC) refers to a heterogeneous subclassification of breast tumors that by definition lack expression of the estrogen receptor (ER)α, progesterone receptor (PR) and human epidermal growth factor receptor (HER)2. Here, ESR1 is linked to breast neoplasm.